rs2580520
From SNPedia
Orientation | minus |
Stabilized | plus |
Make rs2580520(C;C) |
Make rs2580520(C;G) |
Make rs2580520(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 144909849 |
Gene | SRGAP2B |
is a | snp |
is | mentioned by |
dbSNP | rs2580520 |
dbSNP (classic) | rs2580520 |
ClinGen | rs2580520 |
ebi | rs2580520 |
HLI | rs2580520 |
Exac | rs2580520 |
Gnomad | rs2580520 |
Varsome | rs2580520 |
LitVar | rs2580520 |
Map | rs2580520 |
PheGenI | rs2580520 |
Biobank | rs2580520 |
1000 genomes | rs2580520 |
hgdp | rs2580520 |
ensembl | rs2580520 |
geneview | rs2580520 |
scholar | rs2580520 |
rs2580520 | |
pharmgkb | rs2580520 |
gwascentral | rs2580520 |
openSNP | rs2580520 |
23andMe | rs2580520 |
SNPshot | rs2580520 |
SNPdbe | rs2580520 |
MSV3d | rs2580520 |
GWAS Ctlg | rs2580520 |
Max Magnitude | 0 |
? | (C;C) (C;G) (G;G) | 28 |
---|---|---|
|
Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women.
one SNP (rs2580520) located at a predicted enhancer region of SRGAP2 was consistently associated with a significantly increased risk of breast cancer in a recessive genetic model [Odds Ratio (OR) = 1.66, 95% confidence interval (CI) = 1.16-2.36 for stage 2 samples; OR = 1.51, 95% CI = 1.16-1.97 for combined samples, respectively].
[PMID 28912560] The SRGAP2 SNPs, their haplotypes and G × E interactions on serum lipid traits.